Expert Interviews

Thought-provoking interviews with industry experts on topics critical to the diagnosis, treatment, and prevention of progressive eye health

Early monoclonal antibody treatment of COVID-19 beneficial for high-risk COVID-19 patients

Sotrovimab, a monoclonal antibody, appears to reduce the risk of progression of mild-to-moderate cases of COVID-19 in patients at high risk of progression.

Influence of universal face masks on endophthalmitis risk post-anti-VEGF injections

Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.

FDA-approved eye drops target presbyopia patients

Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence.